For instance, Cheuk et al. developed a chimeric antibody 3A11ScFvFc (mice antibody Fv + Human IgG1Fc) to specifically target FGFR4 in HCC [69]. The gene discussed is FGFR4; the disease is hepatocellular carcinoma.